RxDoctor Payments Data

Floriano Marchetti, MD

Colon & Rectal Surgery · Miami, FLNPI 1922063882

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Applied Medical Resources Corporation at 24.0% of the total. Reporting peaked in 2020 at $1,578 and has fallen 98.5% since, to $23 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in FL, where the typical reported total is $4,865.

$4,584in general payments, 2019–2025

Across 28 payments — averaging $163.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Applied Medical Resources Corporation$1K
  • Medtronic$1K
  • Covidien LP$575
  • Intuitive Surgical$573
  • Innovation Technologies Inc$357
  • THD America, Inc.$278
  • plus $598 from 8 others

What the payments were for

  • Consulting fees$1,67537%
  • Travel & lodging$1,08824%
  • Food & beverage$1,74638%
  • Education$752%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,584 in reported general payments places this provider in the 45th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$50,842
Medicare patients
127
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate13$55
Metronidazole17$47
Meloxicam12$16

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →